Welcome to the Phagenesis LinkedIn page! 

At Phagenesis, we are dedicated to transforming the way dysphagia is treated.Dysphagia, or difficulty swallowing, can be a debilitating condition that affects millions of people worldwide. 

We believe that everyone deserves the ability to enjoy their meals and live their lives to the fullest, which is whywe have developed the Phagenyx - a revolutionary product that uses pharyngeal electrical stimulation (PES) to treat dysphagia. 

The Phagenyx is a simple, non-invasive device that stimulates the nerves in the pharynx, helping patients regain control of their swallowing function. Our product has been rigorously tested in clinical trials and has been shown to significantly improve swallowing ability in patients with dysphagia. 

As a company, we are committed to advancing the field of dysphagia care through innovative technology and evidence-based practices. We work closely with healthcare providers and patients to ensure that our product meets the highest standards of safety and efficacy. 

We are proud to be changing the paradigm of dysphagia care, and we invite you to join us in our mission to improve the lives of millions of people around the world. Follow our page to stay up-to-date on the latest news and developments in dysphagia care, and to learn more about the Phagenyx and how it is helping patients overcome dysphagia.

MedTech Innovator

Inventages Venture Capital Investment Inc.

Phagenesis Ltd

We'll be at #ISC2024 this week in Phoenix, AZ! Dr. Andrei Alexandrov will be sharing observations from the first US patient experiences with the #Phagenyx #Neurostimulation System. Attend his presentation and drop by the booth to learn how Phagenyx can help #stroke #patients  who struggle to swallow. 

Scott Grant
Alyssa Cook
Reinhard Krickl

#justgettingstarted #PES #icu #criticalcare 

#thankyou to the PhEAST Clinical Trial Project Management team for hosting an incredible day of education and training in Nottingham, UK. It really takes a village to execute a clinical trial at the highest level and we couldn’t be more proud to partner with a team like this!

Learn more about the PhEAST trial here - https://lnkd.in/gQnG93Te

#teamworkmakesthedreamwork #phagenyx #pheast #PES #criticalcare #ICU #dysphagia

Another incredible patient story from Banner Health and University of Arizona College of Medicine - Phoenix. Jeremy Hogue, the former University of Southern California #Football  Academic All-American Center suffered a stroke, affecting his speech, the right side of his body and how well he could swallow. 

Under Chief of Neurology Dr. Andrei Alexandrov and the medical and speech-language pathology team at Banner, Jeremy received #neurostimulation treatment with #Phagenyx to restore swallowing control. 

“It’s validating, that’s how I’m feeling. It’s pretty cool to say that I’ve been doing this almost six months and in six days I finally have dramatic improvement."

#believe #teamworkmakesthedreamwork #trojans 

HSTS

DNSSEC

Person Schema

Linode

SMTP2GO

Healthcare

Cari Manypenny

HR Manager

Claire Collins

Vice President, Global Marketing

Anil Keni

Assistant Accountant

Aqib Yaseen

Clinical Specialist

Quality Assurance Engineer

Catherine Pratt

Vice President Therapy Development

Scott Grant

Quality Engineer

Stephen Halstead

Drew Burdon

Fred Edenius

Daniel Green

Michael Sjostrom

Mark Wyatt

Oern Stuge

Chad Hoskins

Tarja Barnes

Chief Financial Officer

Rebecca Sheridan

Head of Quality Assurance and Regulatory Affairs

Conor Mulrooney

Co-Founder, COO & Board Member

Shaheen Hamdy

Co-Founder, CSO & Board Member

Europe Acquired Companies (Top 10K)

Health Care Acquired Companies With Less Than $500M in Revenue

United Kingdom Biotechnology Companies

Europe Acquired Companies With Fewer Than 1000 Employees (Top 10K)

Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.

EQT Life Sciences

Sectoral Asset Management

Series D - Phagenesis

Non Equity Assistance - Phagenesis

Series B - Phagenesis

Series A - Phagenesis

Manchester

United Kingdom

Europe

Phagenesis

Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing

Phagenesis’ $42m Series D Financing Round

Phagenesis raises $42m to take medical device for swallowing disorders to the US

Phagenesis Closes $42M Series D Financing

Phagenesis sucks in $42M for 'game changing' dysphagia device

British medical device developer Phagenesis raises $42M Series D for swallowing dysfunction, dysphagia

Report: Pharyngeal neurostim company Phagenesis raises $42M

Phagenesis raises £33m in Series D funding round

A neurostimulation device designed to restore neurological control of swallowing in patients with dysphagia through Pharyngeal Electrical Stimulation (PES).

A treatment method delivered by the Phagenyx System, using electrical stimulation to improve swallowing function in dysphagia patients.

The Phagenyx System customizes electrical stimulation levels based on individual patient sensory capacity to optimize treatment efficacy.

A component of the Phagenyx System that serves both for feeding and delivering electrical stimulation to the patient.

Rwanda

Africa

Switzerland

India

Asia

HTML5

Lightbox

Vimeo

Wordpress

Modernizr

Microsoft Outlook

Google Analytics

jQuery

Apache Server

Google Fonts

Rymo Medical is a competitor of Phagenesis that operates in the same industry, providing similar products or services.

Rymo Medical

Eswallow USA is a competitor of Phagenesis specializing in similar solutions or products.

Eswallow USA

Swallow Solutions is a competitor of Phagenesis, offering comparable solutions or products.

Swallow Solutions

Soligenix is an alternative and possible competitor to Phagenesis, operating in a related industry.

Soligenix

Semma Therapeutics is an alternative and possible competitor to Phagenesis, operating in a related industry.

Semma Therapeutics

Pathway Genomics is an alternative and possible competitor to Phagenesis, operating in a related industry.

Pathway Genomics

Ampcare is a primary competitor of Phagenesis, offering similar solutions or products.

Ampcare

Vivo Smart Medical Devices is a primary competitor of Phagenesis, providing similar products or services.

Vivo Smart Medical Devices

Juvent Co is a top competitor of Phagenesis, offering similar solutions or products.

Juvent Co

MediQuest Therapeutics Inc is a top competitor of Phagenesis, providing similar products or services.

MediQuest Therapeutics Inc

Cyto Pulse Sciences Inc is a top competitor of Phagenesis, offering comparable solutions or products.

Cyto Pulse Sciences Inc

OrthoSpineNews is a top competitor of Phagenesis, operating in a related industry.

OrthoSpineNews

Phagenesis Limited is a company that provides a privacy policy for its website, www.phagenesis.com. The company does not collect personal data from users unless they contact them through the contact form.

news impact assignment basic	general	May 4, 2024 5:41 AM	6ec34196
public peers	general	May 4, 2024 5:41 AM	657b4643
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 4, 2024 5:41 AM	4a887d36
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	8920a04e
crunchbase profile	general	Nov 25, 2024 9:49 AM	4717bf7d
li profile	general	May 4, 2024 5:41 AM	14d9e9e1
translate crunchbase fundingrounds	general	Nov 25, 2024 2:05 PM	4bc9320b
peers	general
news basic	general	May 4, 2024 5:41 AM	00e19519
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:PHAGENESIS

Phagenesis Limited